Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 676 AL 690

Cell therapy for Parkinson's disease: what next?

Bjorklund A, Kordower JH.

Mov Disord. 2013 Jan;28(1):110-5. doi: 10.1002/mds.25343.

The biological clock keeps ticking, but exercise may turn it back

Deslandes A.

Arq Neuropsiquiatr. 2013 Feb;71(2):113-8. doi: 10.1590/s0004-282x2013000200011.

Darkening of white hair in Parkinson's disease during use of levodopa rich Mucuna pruriens extract powder

Munhoz RP, Teive HA.

Arq Neuropsiquiatr. 2013 Feb;71(2):133. doi: 10.1590/s0004-282x2013000200018.

Reduction of bradykinesia of finger movements by a single session of action observation in Parkinson disease

Pelosin E, Bove M, Ruggeri P, Avanzino L, Abbruzzese G.

Neurorehabil Neural Repair. 2013 Jul-Aug;27(6):552-60. doi: 10.1177/1545968312471905. Epub 2013 Feb 7.

Pathologic thoracic spine fracture in presence of Parkinson's disease and diffuse ankylosis: successful management of a challenging condition

Aoki Y, Nakajima A, Sakakibara R, Ohtori S, Takahashi K, Nakagawa K.

BMC Musculoskelet Disord. 2013 Feb 11;14:61. doi: 10.1186/1471-2474-14-61.

Parkinson's disease and α-synuclein: passing it on

Skaper SD.

CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):2. doi: 10.2174/1871527311312010002.

Cognitive functioning in psychiatric disorders following deep brain stimulation

Bergfeld IO, Mantione M, Hoogendoorn ML, Denys D.

Brain Stimul. 2013 Jul;6(4):532-7. doi: 10.1016/j.brs.2013.01.003. Epub 2013 Jan 29.

Engrailed homeobox transcription factors as potential markers and targets in cancer

McGrath SE, Michael A, Pandha H, Morgan R.

FEBS Lett. 2013 Mar 18;587(6):549-54. doi: 10.1016/j.febslet.2013.01.054. Epub 2013 Feb 7.

Juvenile parkinsonism, hypogonadism and Leigh-like MRI changes in a patient with m.4296G>A mutation in mitochondrial DNA

Martikainen MH, Kytövuori L, Majamaa K.

Mitochondrion. 2013 Mar;13(2):83-6. doi: 10.1016/j.mito.2013.01.012. Epub 2013 Feb 7.

Glaucoma: an extension of various chronic neurodegenerative disorders

Jindal V.

Mol Neurobiol. 2013 Aug;48(1):186-9. doi: 10.1007/s12035-013-8416-8. Epub 2013 Feb 10.

The MEF2 family and the brain: from molecules to memory

Dietrich JB.

Cell Tissue Res. 2013 May;352(2):179-90. doi: 10.1007/s00441-013-1565-2. Epub 2013 Feb 9.

Is rosmarinic acid underestimated as an experimental cardiovascular drug?

Ferreira LG, Celotto AC, Capellini VK, Albuquerque AA, Nadai TR, Carvalho MT, Evora PR.

Acta Cir Bras. 2013;28 Suppl 1:83-7. doi: 10.1590/s0102-86502013001300016.

Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults

Seligman SC, Kamath V, Giovannetti T, Arnold SE, Moberg PJ.

Aging Ment Health. 2013;17(5):564-70. doi: 10.1080/13607863.2013.768208. Epub 2013 Feb 12.

Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited

Perez-Lloret S.

Eur J Neurol. 2013 Nov;20(11):1427-8. doi: 10.1111/ene.12113. Epub 2013 Feb 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias